Excel Diagnostics and Nuclear Oncology Center
Excel Diagnostics and Nuclear Oncology Center
Houston, Texas, United States5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer | Solid Malignancies | Recruiting | Phase 1 | 2026-10-07 | NCT07505771 | |
| Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate adenocarcinoma, prostate cancer, prostate disorder | Active, not recruiting | Phase 3 | 2026-08-14 | NCT06235151 | |
| Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain | Neoplasms by Site, bone disorder, musculoskeletal system disorder, neoplasm | Recruiting | Phase 1 | 2026-05-14 | NCT07197645 | |
| Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 2 | 2026-04-15 | NCT05153772 | |
| Targeted Alpha Therapy With 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of Castration-resISTant Prostate Cancer (TATCIST). | Metastatic Castration Resistant Prostate Cancer | Active, not recruiting | Phase 2 | 2026-04-03 | NCT05219500 |